Akebia Therapeutics, Inc. (AKBA) stock
AKBANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.41+0.01 (+2.12%)
Close on Nov 18, 2026Market cap $113.31MP/E –Yield –
Akebia Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Akebia Therapeutics's EV/EBITDA was 45.4× on Jul 31, 2026.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 45.4× | +28.1 |
| 2025 | Dec 31, 2025 | 17.3× | – |
See a number that looks wrong?